What is a stock summary page? Click here for an overview.
Business Description
Akoya Biosciences Inc
NAICS : 334516
SIC : 3821
ISIN : US00974H1041
Description
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | -0.05 | |||||
| Debt-to-Equity | -14.22 | |||||
| Debt-to-EBITDA | -2.82 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -4.24 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.8 | |||||
| 3-Year EBITDA Growth Rate | 16.9 | |||||
| 3-Year EPS without NRI Growth Rate | 13 | |||||
| 3-Year FCF Growth Rate | 14.9 | |||||
| 3-Year Book Growth Rate | -63.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 23.35 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.97 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.94 | |||||
| 9-Day RSI | 61.7 | |||||
| 14-Day RSI | 55.39 | |||||
| 3-1 Month Momentum % | -21.21 | |||||
| 6-1 Month Momentum % | -39.25 | |||||
| 12-1 Month Momentum % | -33.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.61 | |||||
| Quick Ratio | 0.4 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 286.76 | |||||
| Days Sales Outstanding | 62.39 | |||||
| Days Payable | 115.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.8 | |||||
| Shareholder Yield % | -6.26 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.74 | |||||
| Operating Margin % | -46.79 | |||||
| Net Margin % | -59.45 | |||||
| EBITDA Margin % | -37.13 | |||||
| FCF Margin % | -40.45 | |||||
| ROE % | -338.02 | |||||
| ROA % | -35.68 | |||||
| ROIC % | -42.59 | |||||
| 3-Year ROIIC % | -25.24 | |||||
| ROC (Joel Greenblatt) % | -135.21 | |||||
| ROCE % | -42.67 | |||||
| Moat score | 4 | |||||
| Tariff score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.79 | |||||
| EV-to-EBIT | -3.21 | |||||
| EV-to-Forward-EBIT | -3.74 | |||||
| EV-to-EBITDA | -4.01 | |||||
| EV-to-Forward-EBITDA | -2.87 | |||||
| EV-to-Revenue | 1.49 | |||||
| EV-to-Forward-Revenue | 1.54 | |||||
| EV-to-FCF | -3.68 | |||||
| Price-to-GF-Value | 0.35 | |||||
| Earnings Yield (Greenblatt) % | -31.15 | |||||
| FCF Yield % | -51.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AKYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Akoya Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 79.961 | ||
| EPS (TTM) ($) | -0.97 | ||
| Beta | 1.35 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 75.15 | ||
| 14-Day RSI | 55.39 | ||
| 14-Day ATR ($) | 0.11691 | ||
| 20-Day SMA ($) | 1.15178 | ||
| 12-1 Month Momentum % | -33.84 | ||
| 52-Week Range ($) | 0.931 - 3.42 | ||
| Shares Outstanding (Mil) | 49.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akoya Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akoya Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Akoya Biosciences Inc Frequently Asked Questions
What is Akoya Biosciences Inc(AKYA)'s stock price today?
The current price of AKYA is $1.27. The 52 week high of AKYA is $3.42 and 52 week low is $0.93.
When is next earnings date of Akoya Biosciences Inc(AKYA)?
The next earnings date of Akoya Biosciences Inc(AKYA) is 2025-08-05 Est..
Does Akoya Biosciences Inc(AKYA) pay dividends? If so, how much?
Akoya Biosciences Inc(AKYA) does not pay dividend.
Guru Commentaries on NAS:AKYA
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers